Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Terminated 6Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Breast 1

Conditions

Neoplasms 2Breast Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × RG-1507 monoclonal antibody × Clear all
NCT00400361 2016-11-02

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

Hoffmann-La Roche

Phase 1 Completed
98 enrolled
Tumor-Agnostic

Neoplasms

NCT00882674 2016-11-02

A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Hoffmann-La Roche

Phase 1 Completed
8 enrolled
Breast

Breast Neoplasms

NCT00560144 2016-11-01

A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.

Hoffmann-La Roche

Phase 1 Completed
34 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡